Clinical trials
Tumor clinical trials
Below are recruiting tumor clinical trials, each written for real people, not researchers. We’re tracking 3,388 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07275463Enrolling by invitationPhase 2
Study of DB8 imaging in estrogen receptor positive and negative breast cancer
This trial uses a special imaging agent called DB8 to see how it builds up in breast tumors. It compares results between women with estrogen receptor-positive and estrogen receptor-negative cancers to help improve detection.
TomskAges 18–80 - NCT07254104Enrolling by invitationEarly Phase 1
PET imaging for hard-to-treat pituitary tumors
This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.
BeijingAges 18–80 - NCT07093151Enrolling by invitation
Comparing blood pressure goals after brain tumor surgery
This study looks at two different blood pressure targets after surgery to remove a brain tumor. The goal is to see which target helps patients recover better and have fewer complications.
Nashville, TennesseeAges 18 years+ - NCT07091396Enrolling by invitation
Home brain stimulation to improve thinking and language
This trial tests a safe, mild electrical stimulation device (tDCS) that you can use at home. It may help improve your thinking or language after a stroke, brain tumor, or other brain condition.
Rochester, MinnesotaAges 18 years+ - NCT07085494Enrolling by invitation
Brain training for kids after a brain tumor
This study tests if a special computer training program, which uses brain activity (neurofeedback) and thinking exercises, can help children who survived a brain tumor improve their attention and memory. If your child struggles with focus or planning after treatment, this may offer extra support.
Hong KongAges 6–18 - NCT07064369Enrolling by invitation
Thyroid tumor study: new predictive factors
This study looks at different types of thyroid tumors to find new factors that might help predict how the disease will progress or respond to treatment. If you have been diagnosed with a thyroid tumor, you may be able to join.
RomaAges 18 years+ - NCT07026370Enrolling by invitation
Chinese Health Study: Long-term health follow-up
This study is following up with people who already took part in a large health survey in China. It looks at how multiple health conditions develop over time and why some people stay healthier than others.
Beijing, Beijing MunicipalityAges 20 years+ - NCT07023848Enrolling by invitationEarly Phase 1
Imaging study for HER2-positive cancers using a special tracer
This study uses a radioactive tracer to take pictures of tumors that have a protein called HER2. It may help doctors see where the cancer is in your body and could guide future treatment decisions.
Wuxi, JiangsuAges 18–75 - NCT06925685Enrolling by invitation
Long-term follow-up after CAR T-cell therapy
This study monitors participants who received a certain type of CAR T-cell therapy for cancer. It helps researchers understand long-term effects and safety.
Buffalo, New YorkAges Any age - NCT06894927Enrolling by invitation
Hearing check for adults 50 and over
This trial offers a free hearing check for adults aged 50 and older. It aims to detect any hearing changes early and can help you understand your hearing health better.
Hradec Králové, Czech RepublicAges 50 years+ - NCT06743958Enrolling by invitation
Prehab for kids with leg bone or soft tissue sarcomas
This study tests whether a prehabilitation program (special exercises and support before cancer treatment) helps children and teens with leg sarcomas recover better. It aims to improve strength and mobility after treatment.
Munich, BavariaAges 6–18 - NCT06705049Enrolling by invitation
Study on cancer spread to the lining of the brain
This study looks at how solid tumors spread to the lining of the brain and spinal cord. It aims to understand this condition better by reviewing patient records.
ShanghaiAges 18–80 - NCT06603987Enrolling by invitationPhase 1/Phase 2
Testing a new drug combination for recurrent solid tumors
This early-phase trial tests a new combination of drugs (CICS-1 and SPM-011) along with a special imaging scan to see if they can help people with hard-to-treat cancers that have come back. It may be an option if standard treatments are no longer working.
Osaka, OsakaAges 18–85 - NCT06584877Enrolling by invitation
Understanding how childhood tumors and birth conditions start
This study looks at leftover tissue samples from children who have had tumors or birth conditions. Researchers want to learn more about how these conditions develop, and you may help if you or a relative fits the criteria.
CambridgeAges Any age - NCT06391294Enrolling by invitation
Brain stimulation study for language mapping during awake surgery
This study uses gentle electrical stimulation on the brain during awake surgery to understand how language works. It's for people having brain tumor removal or epilepsy monitoring who can speak English and do not have serious speech or thinking problems.
Chicago, IllinoisAges 18–80 - NCT06388252Enrolling by invitation
ECT changes in melanoma skin tumors
This study tests how electrochemotherapy (ECT) changes the area around melanoma tumors in the skin. It may help doctors understand why ECT works and who benefits most.
LjubljanaAges 18–100 - NCT06145139Enrolling by invitation
Liquid biopsy for kidney cancer: tracking tumor DNA after surgery
This study looks at whether a simple blood test can detect tiny bits of kidney cancer DNA after surgery. If successful, it could help doctors spot a return of cancer earlier than scans alone.
Aarhus NAges 18 years+ - NCT06099431Enrolling by invitation
Bone plate for jaw reconstruction after benign tumor removal
This trial is testing a bone plate used to rebuild the lower jaw after removing a non-cancerous growth. It may help patients who need surgery to remove a benign lesion from the center of their jawbone.
Tanta, Gharbia GovernorateAges 12–50 - NCT05486520Enrolling by invitation
Low-field MRI test for breast cancer screening
This study tests a special MRI scanner that uses much weaker magnets to look at breast tissue for screening and possible follow-up. It may help find breast changes while aiming to reduce noise and discomfort compared with standard MRI.
Boston, MassachusettsAges 20–80 - NCT05435859Enrolling by invitation
Mapping the brain area for speech during surgery
This study uses tiny brain electrodes placed during surgery to better understand how a brain region helps with speech. The results may guide safer brain mapping during surgery for people with epilepsy or brain tumors.
San Francisco, CaliforniaAges 18–70 - NCT05238909Enrolling by invitation
Tracking tumor burden in people with NF1
This study looks for better ways to measure how much tumor activity people with neurofibromatosis type 1 (NF1) have over time. The goal is to develop “biomarkers,” which are test results that may help doctors track disease more easily.
Chicago, IllinoisAges Any age - NCT05160480Enrolling by invitation
Total-body PET scan using FDA-approved tracers for prostate or NET cancer
This pilot study tests a total-body PET scan with approved tracer medicines to help detect cancer spread in people with suspected metastatic prostate cancer or certain neuroendocrine tumors (NETs). You may be able to join if recent scans already suggest metastasis and you can safely complete the scan timing and positioning.
Sacramento, CaliforniaAges 18 years+ - NCT05014841Enrolling by invitation
Brain electrode study of speech across different languages
This study uses electrodes placed on the brain during surgery to understand how speech is represented in different languages. It may help doctors better map language areas and improve surgical planning for people having brain surgery.
San Francisco, CaliforniaAges 18–70 - NCT04879121RecruitingPhase 2
Larotrectinib for tumors with extra NTRK gene copies
This trial studies larotrectinib, a targeted medicine, in people with solid tumors that have extra copies (amplification) of the NTRK1, NTRK2, or NTRK3 gene. It’s for cancers that have already been treated with standard options or where standard options are unlikely to help.
Houston, TexasAges 16 years+
Hear when a new Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tumor?
- Yes. Clin2 currently lists 3,388 recruiting tumor studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tumor trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tumor trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.